This Month's Profile Group: Medtech Start-Ups Innovate in Urinary Incontinence features profiles of Floelle, InControl Medical, NexHand, and Solace Therapeutics. Plus these Start-Ups Across Health Care: Ablative Solutions, Epiomed Therapeutics, Halo Healthcare, and Thrombolytic Science International.

The various triggers that case nausea and vomiting are conveyed to the brain via different pathways that converge to create a final common pathway leading to the vomiting center in the medulla region of the brain. Previous attempts to develop drugs that target this common pathway have failed in the clinic because they produced anxiety and panic attacks, but Epiomed Therapeutics Inc. thinks it has discovered the reasons for the anxiety and is developing a redesigned product devoid of this side effect.

In Vivo briefly describes these recently founded companies: BioCritica, Entericon, Epiomed Therapeutics, Radisens Diagnostics, Sapiens and Sova Pharmaceuticals.